Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

Presentation TCT 2019

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Presenter: Bernard Gersh

September 28, 2019

News Conference News ESC 2019

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

Todd Neale

September 13, 2019

News Conference News ESC 2019

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

Shelley Wood

September 04, 2019

News Conference News ESC 2019

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Shelley Wood

September 01, 2019

News Daily News

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Todd Neale

August 23, 2019

News Daily News

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Yael L. Maxwell

August 20, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2019

Shelley Wood

July 31, 2019

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

Yael L. Maxwell

June 12, 2019

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Daily News

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

Yael L. Maxwell

May 10, 2019

News Daily News

Lengthy Antibiotic Use Later in Life Tied to Higher CV Risk for Women

Caitlin E. Cox

April 25, 2019

News Daily News

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Shelley Wood

January 21, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Yael L. Maxwell

January 11, 2019

Presentation ISET 2018

Can We Personalize Risk Stratification for Sudden Death?

Presenter: Jeffrey Goldberger

November 16, 2018

Advertisement

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Risk Stratification for Sudden Cardiac Death and ICD Implantation

Primary Prevention ICDs Still Render Better Survival, Even in Modern HFrEF Patients

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

TCTMD’s Top 10 Most Popular Stories for July 2019

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Warning Signs: Many Cardiac-Arrest Victims Visited Doctors, Emergency Rooms Prior to Events

Lengthy Antibiotic Use Later in Life Tied to Higher CV Risk for Women

AAA Rupture Rate in England Supports Current Thresholds for Surveillance, Intervention—With Some Caveats

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Half of TAVR Patients Develop Potentially Dangerous Conduction Abnormalities

Can We Personalize Risk Stratification for Sudden Death?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content